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Hyperautofluorescent Dots 
are Characteristic in Ceramide 
Kinase Like-associated Retinal 
Degeneration
Jesse D. Sengillo3, Galaxy Y. Cho4, Maarjaliis Paavo2, Winston Lee2, Eugenia White5, 
Ruben Jauregui6, Janet R. Sparrow2,7, Rando Allikmets2,7 & Stephen H. Tsang1,2,7,8
There is a lack of studies which seek to discern disease expression in patients with mutations that alter 
retinal ceramide metabolism, specifically in the ceramide kinase like (CERKL) gene. This cross-sectional 
case series reports a novel phenotypic manifestation of CERKL-associated retinopathy. Four unrelated 
patients with homozygous CERKL mutations underwent a complete ocular exam, spectral-domain 
optical coherence tomography, short-wavelength fundus autofluorescence (SW-AF), quantitative 
autofluorescence (qAF), and full-field electroretinogram (ffERG). Decreased visual acuity and early-onset 
maculopathy were present in all patients. All four patients had extensive hyperautofluorescent foci 
surrounding an area of central atrophy on SW-AF imaging, which has not been previously characterized. 
An abnormal spatial distribution of qAF signal was seen in one patient, and abnormally elevated qAF8 
signal in another patient. FfERG recordings showed markedly attenuated rod and cone response in 
all patients. We conclude that these patients exhibit several features that, collectively, may warrant 
screening of CERKL as a first candidate: early-onset maculopathy, severe generalized retinal dysfunction, 
peripheral lacunae, intraretinal pigment migration, and hyperautofluorescent foci on SW-AF.
The ceramide kinase like (CERKL, 608381) gene encodes an anti-oxidant protein that, when harboring bial-
lelic mutations, causes an autosomal recessive retinal degeneration1–7. The function of CERKL has largely been 
ascribed to the protection of photoreceptors from oxidative stress, and studies have identified a variety of pos-
sible mechanisms, including a role in sphingolipid and ceramide metabolism1,4,8 and interactions with calcium 
sensor proteins in the retina9. Recent evidence suggests that CERKL interacts with mitochondrial thioredoxin 2 
(TRX2), maintaining TRX2 in a reduced state10. TRX2 is critical for maintaining cellular redox balance, and when 
absent, can lead to hypoxia-induced apoptosis10–14. Thus, without properly functioning CERKL, photoreceptors 
are thought to be more susceptible to oxidative stress and exist in a pro-apoptotic state, leading to severe degen-
eration of both rod and cone photoreceptors2,6.
In one cohort of 272 Spanish retinitis pigmentosa (RP) patients, CERKL was found to be a commonly mutated 
gene, with the p.Arg257Stop mutation being the most frequent15. Additional studies have identified missense, 
splice-site, nonsense, and frameshift mutations in CERKL as the cause of retinal degeneration7,16–18. However, few 
studies have sought to characterize the CERKL-associated retinopathy phenotype16–18. Patients typically exhibit an 
early maculopathy with severely depressed rod- and cone-responses, which vary in relation to each other. This typi-
cal ERG finding and early involvement of the macula have led some to categorize the condition as a cone-rod dystro-
phy rather than autosomal recessive retinitis pigmentosa (arRP)18, as it is traditionally cited7,15–17. Other previously 
described features include lacunae of degeneration in the periphery and intraretinal pigment migration16–18.
1Jonas Children’s Vision Care, and Bernard & Shirlee Brown Glaucoma Laboratory, New York, USA. 2Department of 
Ophthalmology, Columbia University, New York, NY, USA. 3Department of Internal Medicine, Reading Hospital, 
West Reading, PA, USA. 4Frank H. Netter MD School of Medicine, Quinnipiac University, North Haven, CT, USA. 
5Department of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, USA. 6Weill Cornell 
Medical College, New York, NY, USA. 7Department of Pathology & Cell Biology, Columbia University, New York, NY, 
USA. 8Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 
USA. Correspondence and requests for materials should be addressed to S.H.T. (email: sht2@cumc.columbia.edu)
Received: 9 July 2018
Accepted: 27 September 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIeNTIFIC RePoRtS |           (2019) 9:876  | DOI:10.1038/s41598-018-37578-4
Early identification and diagnosis are important in the management of patients with CERKL-associated retin-
opathy, as it manifests more severely than most similarly appearing cone-rod and rod-cone dystrophies. This 
retrospective analysis seeks to further illustrate the CERKL-associated retinopathy phenotype, expand on the 
previously described imaging and electrodiagnostic characteristics, and report a novel SW-AF imaging feature. 
Four cases of retinopathy caused by homozygous nonsense mutations in CERKL are presented. Key features seen 
on ophthalmoscopy, spectral-domain optical coherence tomography (SD-OCT), en face short-wavelength fundus 
autofluorescence (SW-AF), quantitative autofluorescence (qAF), and full-field electroretinography (ffERG) are 
described.
Materials and Methods
Subjects. Retrospective review of patient charts and imaging data presented in this study was approved by 
the Edward S. Harkness Eye Institute and Columbia University Internal Review Boards and adhered to the tenets 
of the Declaration of Helsinki. The data presented in this study, including images and genetic testing results, are 
not identifiable to individual patients. Informed consent was obtained as outlined by the Columbia University 
Medical Center IRB-approved protocol AAAR0284.
Retinal Imaging. SW-AF and SD-OCT images were acquired by a Spectralis HRA + OCT device 
(Heidelberg Engineering, Heidelberg, Germany) for all four patients following dilation, as previously described19. 
SW-AF images were acquired using a 30-degree field and 1536 × 1536 pixel resolution with a 486-nm wavelength 
stimulus and 521 nm barrier filter. An 870 nm light source with real-time registration of an infrared reflectance 
image was used to acquire all SD-OCT images. Scans were taken horizontally through the fovea (high resolution 
mode, 9 mm, ART, average of a minimum of 50 images). Quantitative autofluorescence (qAF) was performed 
and analyzed in patients 2 and 3 (P2 and P3). Protocols for the acquisition of AF images that meet the quality 
standards necessary for quantification are previously described20. Fundus AF images (30°; 488-nm excitation) for 
these analyses were acquired using a modified Spectralis HRA + OCT camera (Heidelberg, Germany) with the 
addition of an internal fluorescent reference to correct for variations in laser power and sensitivity (detector gain). 
Prior to acquisition, the fundus was exposed to the AF light for 20 to 30 seconds to bleach rhodopsin, while at 
the same time, focus and alignment were refined to produce a maximum and uniform signal over the entire field. 
Acquired images were analyzed with customized analysis software on the IGOR platform (WaveMetrics, Lake 
Oswego, OR). The software simultaneously recorded the mean GLs of the internal reference and the area within 
eight circularly arranged segments positioned at an eccentricity of approximately 7° to 9°–of which the mean 
value is referred to as qAF8. The size of the segments were scaled to the horizontal distance between the fovea and 
the temporal edge of the optic disc. Control values used in this study consisted of previously published data from 
277 healthy subjects (374 eyes; age range, 5–60 years) without a family history of retinal dystrophy21.
Electroretinography. FfERGs (Diagnosys LLC, Lowell, Massachusetts, USA) were recorded in each eye 
of all patients using either Burian-Allen (BA) contact lenses or DTL recording electrodes in accordance with 
the International Society for Clinical Electrophysiology of Vision (ISCEV) standards in scotopic and photopic 
states22,23. For two patients (P1 and P2), BA contact lenses were used, and 30 Hz-flicker responses were obtained 
through narrow band-passed filtering with subsequent computed averaging24,25.
Genetic analyses. For all patients, DNA was isolated from whole blood lymphocytes for whole exome 
sequencing. Two patient samples (P2 and P4) underwent clinical laboratory improvement amendments 
(CLIA)-approved whole exome sequencing at the Center of Personal Genomic Medicine (PGM), Columbia 
University Medical Center (New York, NY). Whole exome sequencing for P1 was performed by the NIHR 
BioResource (BRIDGE SPEED) study (Cambridge, UK). For P3, whole exome sequencing was performed in 
the laboratory of Dr. Rando Allikmets at CUMC. The allele frequencies of detected variants in P3 were com-
pared to the Exome Aggregation Consortium (ExAC) (Cambridge, MA; http://exac.broadinstitute.org; accessed 
March 2018). The possible effect of detected variants was assessed using a combination of prediction pro-
grams available through the Alamut software version 2.2 (Interactive Biosoftware, Rouen, France; http://www.
interactive-biosoftware.com), using automated computation of this software version.
Results
Clinical Data. A summary of clinical, demographic and genetic characteristics is presented in Table 1. All 
patients (mean age, 31.3; range 22–43) reported a family history consistent with autosomal recessive inheritance. 
Two patients presented with a history of nyctalopia, and all patients described progressive loss of visual acu-
ity. Visual acuity in all patients was not correctable to 20/20, ranging from 20/40 to 20/800 bilaterally (P1) and 
hand-motion (P4). One patient, P4, exhibited clinically significant posterior subcapsular cataracts in both eyes. 
All patients presented with extensive maculopathy and retina-wide degeneration on fundoscopy with evidence 
of chorioretinal lacunar-like degeneration (Fig. 1) in the periphery of two patients (P1 and P4), and bone-spicule 
pigment deposition in three patients (P1, P2, and P4). Intraretinal pigment observed in P1 appeared to cluster 
between the peripheral lacunae. A melanocytoma could be appreciated in the left eye nasal to the optic disc of P3.
Retinal imaging. SW-AF revealed marked atrophy of the central macula in all patients. P1 and P4 had a 
large, well-delineated area of central atrophy (OD/OS: 9.1mm2/9.2mm2 and 11.3mm2/13.3mm2 in P1 and P4, 
respectively) through which large choroidal vessels were visible on fundoscopy. P4 had some evidence of spared 
foveal AF signal in both eyes. P2 presented with a more confined bull’s-eye lesion of RPE loss, and P3 exhibited 
smaller coalescing atrophic lesions. Small hyperautofluorescent foci (generally <120 µm in diameter) of varying 
confluence were ubiquitous in the areas immediately surrounding the maculopathy and intermittently present 
among sparsely heterogeneous peripheral RPE atrophy (Fig. 2). An assessment of these foci on SD-OCT was 
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attempted but did not convincingly reveal any spatially corresponding structures. SD-OCT, however, did show 
extensive atrophy of the outer retinal lamina throughout the entire 30-degree field of view of each patient (Fig. 3). 
The ellipsoid zone was visibly absent or sparsely granular in all cases. Deterioration of the RPE layer in the mac-
ula was most evident on SD-OCT scans in P1, yielding increased signal transmittance to the choroidal layer. No 
patients exhibited cystoid macular edema. Levels of qAF8 in both eyes of P2 fell within the 95% confidence inter-
vals for healthy eyes (Fig. 4D), however, color maps coded according to qAF-units revealed abnormal spatial dis-
tribution (Fig. 4B, right column) as compared to an age-matched healthy retina (Fig. 4A, right column). Analyzed 
qAF8 values in P3 in both eyes were significantly increased with respect to corresponding healthy eyes (Fig. 4D) 
and exhibited >800 qAF-units in regions around the maculopathy (Fig. 4C, center column).
Full-field electroretinography (ffERG). All patients presented with marked attenuation of both scotopic and 
photopic responses, consistent with generalized retinal dysfunction (Fig. 5). Rod-specific b-wave amplitudes were 
extinguished in all patients. DTL-recording electrodes were used to measure rod and cone function in patients 
P3 and P4. P3 exhibited 30 Hz-flicker responses less than 10µV in the right eye and 13uV in the left. These 
responses were non-detectable in P4. A specialized protocol detected residual photopic 30 Hz-flicker responses 
in two patients (P1, P2), using BA contact lens electrodes, narrow band pass filtering and subsequent computed 
averaging.
Genotyping. Disease-causing CERKL variants were detected in all patients (Table 1) by whole-exome 
sequencing (WES). Homozygous c.847 C > T (p.R283*) nonsense variants were identified in P1 and P2, both of 
Patient P1 P2 P3 P4
Age/Sex 36/M 24/F 22/M 43/F
Ethnicity* Irish Irish Indian Greek
Genotype Homozygous p.Arg283Ter Homozygous p.Arg283Ter Homozygous p.Arg435Ter Homozygous p.Arg257Ter
BCVA (OD, OS) 20/800, 20/800 20/50, 20/50 20/50, 20/40 20/HM, 20/HM
Maculopathy Well-delineated Bulls-eye Granular Well-delineated
Intraretinal Pigment Yes Yes No Yes
Lacunae Yes No No Yes
Cataract No No No PSC**
Table 1. Patient Summary. Clinical characteristics of four CERKL-associated retinopathy patients. *Information 
obtained by history; **PSC; posterior subcapsular cataract.
Figure 1. Characteristic fundus in CERKL-associated retinopathy. Digital color fundus photographs in the 
right (A) and left (B) eyes of P1 with confirmed homozygous frameshift mutations in CERKL. An area of 
macular atrophy is evident, revealing underlying choroidal vessels. A pale disc and attenuated vessels are 
also seen bilaterally. Peripheral findings (C) include punched-out appearing, lacunar-like degeneration with 
intraretinal pigment migration.
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Irish descent, and c.769 C > T (p.R257*) was found in P4. The two nonsense variants are predicted to be patho-
genic, resulting in the interruption of the reading frame by a premature stop codon in exons 6 and 5, respectively. 
WES in P3 detected segregating novel homozygous nonsense variants, c.1303 C > T (p.R435*), and compound 
heterozygous missense variants in CDH23, c.429 + 4 G > A (p.?) and c.6197 G > A (p.R2066Q) (AlignGVGD: 
class 0; SIFT score, 0.36). The allele frequencies of the detected CDH23 variants were 1.2% and 4.6%, respectively, 
Figure 2. Fundus autofluorescence imaging in CERKL-associated retinopathy. SW-AF imaging of four patients 
with CERKL-retinopathy shows large areas of RPE loss in the macula. P1 and P4 show the most well-delineated 
and largest area of maculopathy. Outside of the area of atrophy in all patients, sparse RPE loss is seen with 
intermixed numerous hyperautofluorescent foci, generally <120 µm in size.
Figure 3. SD-OCT imaging in CERKL-associated retinopathy. SD-OCT images are shown for patients P1 
through P4. Extensive peripheral thinning and chorioretinal degeneration is seen in all patients. P1 shows the 
most RPE loss, with increased signal transmittance to the choroidal layers below (yellow arrow).
www.nature.com/scientificreports/
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in the general population of South Asian descent (P3 is Asian Indian), and thus considered frequent, benign var-
iants in individuals from this region.
Discussion
A dense pattern of hyperautofluorescent foci in regions adjacent to atrophy in the macula was observed for all 
cases in this study. These foci were least salient in P2 who presented at the earliest disease stage. The discerni-
bility of these foci seems, interestingly, restricted to SW-AF (488-nm excitation) images and exhibit a pattern of 
accretion with advancing disease severity. These associations and their spatial proximity to degenerative areas 
may posit a bisretinoid lipofuscin toxicity26 pathway in the pathophysiology of CERKL-associated retinopathy, 
although further studies are warranted to investigate this hypothesis. These foci could also theoretically result 
from accumulated ceramide, as the mutated gene causes metabolic dysfunction in this pathway. We also hypoth-
esize that these foci could be groups of pre-apoptotic photoreceptor cells or RPE as the result of oxidative stress, 
which CERKL typically reduces. Thinning of the outer nuclear layer was seen on SD-OCT of all patients and 
intraretinal hyperreflective signals, particularly in P3 and P4, were appreciated within the outer retina. It is pos-
sible that this signal represents remnants of degenerated photoreceptors or even debris of RPE cells that have 
detached from the Bruch’s membrane, which is also seen in other inherited retinal dystrophies. Interestingly, qAF 
signal in the macula was significantly increased only in regions of advanced disease changes associated with RPE 
and photoreceptor degeneration (P3) but not in corresponding areas in the macula at an earlier disease stage prior 
to atrophy (P2). Increased bisretinoid accumulation in photoreceptor outer segments may thus be a downstream 
event in the pathophysiology of CERKL dysfunction as has been observed in other retinal disease27,28.
The phenotype of CERKL-associated retinopathy has traditionally been classified clinically under the spec-
trum of arRP, RP26 (OMIM#608380). Studies in mice interestingly show higher CERKL expression in cones 
compared to rods29, and recent evidence suggest that the clinical presentation and ERG data in three unrelated 
families are more consistent with a cone-rod dystrophy18. Similarly, the presenting symptoms and retinal imaging 
findings more closely resemble a severe cone-rod dystrophy as opposed to RP in each patient of this case series. 
Patients in this study experienced early-onset maculopathy with significantly decreased visual acuity at pres-
entation that are atypical findings for most RP cases. Electroretinography is frequently helpful in determining if 
a dystrophy is representative of a rod-cone (i.e, RP) or cone-rod sequence of degeneration, though this becomes 
increasingly difficult to determine at later stages of disease. Here, three patients had evidence of residual cone 
response in the context of non-detectable scotopic B-waves. However, neither a specialized protocol to measure 
residual rod function nor psychometric testing was performed, yielding any functional comparison between the 
two cell populations difficult. It would be helpful to assess patients earlier in the disease course to more precisely 
categorize the electrophysiological phenotype of this condition. The comparatively severe ERG phenotype noted 
amongst our four patients may also reflect the genotype profile of patients who possess homozygous or com-
pound heterozygous deleterious mutations ranging from nonsense substitutions to single base pair deletions 
causing a frameshift (i.e., a premature termination in all cases).
Taken together, AF retinal imaging of CERKL-associated retinopathy reveals a unique phenotype which 
may assist specialists in arriving at an accurate diagnosis. For patients with early-onset maculopathy, peripheral 
Figure 4. Analysis of quantitative autofluorescence (qAF) in P2 and P3. Average qAF values were calculated in 
8 scaled segments within the macula. (A) Age and ethnicity-matched healthy individual. (B) P2; qAF in P2 were 
found to be comparable to an age-matched healthy retina but exhibited changes in the spatial distribution of AF 
(color map). (C) P3; qAF in P3 were significantly increased in both eyes with respect to corresponding healthy 
eyes. (D) Plot showing the mean and 95% confidence intervals of qAF in healthy eyes with age and the value of 
both eyes of P2 and P3.
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lacunae with pigment migration, hyperautofluorescent dots on AF, and severe generalized retinal dysfunction, 
screening of the CERKL gene is suggested as the first, time- and cost-saving, step before whole exome sequencing. 
WES remains the suggested screening method for patients who exhibit only some of these features. Studies with 
larger cohorts of CERKL patients will be helpful in determining disease progression and further characterizing 
the ffERG phenotype.
Data Availability
Datasets generated and/or analyzed during the current study are available from the corresponding author upon 
reasonable request.
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